Star Health and Allied Insurance Company Limited (NSE:STARHEALTH)
India
· Delayed Price · Currency is INR | Market Cap | 303.15B |
| Revenue (ttm) | 172.68B |
| Net Income (ttm) | 4.46B |
| Shares Out | 587.95M |
| EPS (ttm) | 7.50 |
| PE Ratio | 68.74 |
| Forward PE | 37.02 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 256,823 |
| Average Volume | 451,379 |
| Open | 515.60 |
| Previous Close | 515.60 |
| Day's Range | 513.00 - 521.80 |
| 52-Week Range | 348.30 - 534.00 |
| Beta | 0.10 |
| RSI | 71.51 |
| Earnings Date | Apr 28, 2026 |
About NSE:STARHEALTH
Star Health and Allied Insurance Company Limited provides health insurance products in India. It offers retail health insurance products for individuals, families, children, senior citizens, and persons with pre-existing medical conditions; group health insurance products for employer/employee and non-employer/employee groups, including small-to-medium enterprises; and personal accident and travel insurance products. The company also provides star women care insurance policy that provides surrogacy and oocyte donor covers; and star special care... [Read more]
Financial Performance
In fiscal year 2025, NSE:STARHEALTH's revenue was 161.10 billion, an increase of 14.87% compared to the previous year's 140.25 billion. Earnings were 6.46 billion, a decrease of -23.57%.
Financial StatementsNews
Star Health and Allied Insurance Company Transcript: Q3 25/26
Strong top-line and profit growth driven by improved combined and loss ratios, digital and agency channel expansion, and disciplined execution. Retail health leadership maintained, with robust investment yields and a focus on sustainable ROE amid regulatory and inflationary challenges.
Star Health and Allied Insurance Company Transcript: Q2 25/26
Gross written premium grew 12% year-over-year to INR 8,809 crore, with retail health GWP up 17% and persistency at 98%. Loss ratios and expense ratios improved, while digital and agency channels drove growth. GST exemption boosted demand, and profitability rose 21% year-over-year.
Star Health and Allied Insurance Company Transcript: Q1 25/26
Q1 FY26 saw 13% GWP growth and 44% PAT increase, driven by strong retail and digital channels, improved claims ratios, and ongoing cost discipline. Strategic product innovation and risk-based pricing support profitability amid healthcare inflation.
Star Health and Allied Insurance Company Transcript: Q4 24/25
Maintained retail health insurance leadership with 33% market share and 25% fresh GWP growth, but faced elevated claim ratios and lower profits due to higher frequency and severity of claims. Strategic repricing, digital initiatives, and regulatory reforms are expected to support future profitability.
Star Health and Allied Insurance Company Transcript: Q3 24/25
Strong nine-month FY25 growth in GWP and fresh business, with robust digital and agency expansion, but elevated claim ratios and regulatory changes impacted combined and expense ratios. Price hikes and product innovation are expected to support future improvement.
Star Health and Allied Insurance Company Transcript: Q2 24/25
Strong growth in GWP and digital channels was offset by higher claims ratios due to medical inflation and seasonal factors. Price hikes are being implemented across much of the portfolio, and medium-term targets for doubling GWP and tripling profit by FY28 are maintained.
Star Health and Allied Insurance Company Transcript: Q1 24/25
GWP grew 18% YoY to INR 3,477.76 crores, with PAT up 11% YoY to INR 319 crores. Agency remains the main channel, but banca, corporate, and digital segments are growing faster. Claims ratio rose to 67.6% due to higher medical case frequency and wellness spend.